Pharma — India Other Cases
3 decisions indexed
Page 1 of 1 · 3 total
CBZ Chemicals Ltd v.Kee Pharma Ltd
CBZ Chemicals Ltd filed a petition against Kee Pharma Ltd claiming deprivation of USD 350,000 related to an agreement for the sale of a process design to manufacture Atorvastatin. The court admitted the petition but deferred the appointment of a Provisional Liquidator, giving the respondent one month to pay the due amount with interest.
Kerala Ayurveda Limited v.State Of Kerala
The petitioner sought permission from various state departments, including the Department of Customs/Central Excise, to incorporate a name change in its L2 license. The Commissioner of Excise and the Government rejected these applications, citing violation of the Emblems and Names (Prevention of Improper Use) Act, 1950. The High Court ruled that since the Registrar of Companies had already approved the name change, the subsequent rejection by the Excise authorities was unwarranted.
Brawn Laboratories Ltd. v.Rhone Poulenc Rorer S.A.
The petitioner sought arbitration and an interim injunction under Section 9 of the Arbitration and Conciliation Act, 1996, to restrain the respondents from marketing products like CLEXANE. The dispute centered on the termination of an exclusive license agreement and alleged breach of negative covenants.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.